Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells

Area of Science:

• Neuroscience
• Genetics
• Stem Cell Biology

Background:

• Polyglutamine expansion disorders are linked to expanded CAG repeats, causing polyglutamine expansions in proteins.
• The selective neurotoxicity of these disorders, despite ubiquitous protein expression, remains poorly understood.
• Eleven distinct neuropathies are associated with polyglutamine expansion disorders.

Purpose of the Study:

• To review the application of induced pluripotent stem cell technology in modeling polyglutamine expansion diseases.
• To explore how this technology aids in understanding disease mechanisms and identifying therapeutic targets.
• To examine the impact of polyglutamine expansion on human neurodevelopment and disease.

Main Methods:

• Utilizing induced pluripotent stem cells (iPSCs) to generate specific human neural and glia subtypes.
• Employing iPSCs for cocultures and organoid models.
• Investigating the effects of disease-causing polyglutamine proteins on cellular function using iPSC-derived models.

Main Results:

• iPSC technology enables the generation of relevant human neural cell types for disease modeling.
• These models can recapitulate specific polyglutamine expansion disorder phenotypes and selective vulnerabilities.
• iPSC-derived models facilitate the study of polyglutamine protein effects on cell function and human neurodevelopment.

Conclusions:

• Induced pluripotent stem cells are a valuable tool for modeling polyglutamine expansion diseases.
• This technology aids in understanding selective neurotoxicity and identifying therapeutic strategies.
• Ongoing challenges and limitations in iPSC-based modeling require further investigation.